Skip to main content

Table 1 Descriptive comparison of screening and symptomatically detected cancers

From: Breast cancer tumour growth modelling for studying the association of body size with tumour growth rate and symptomatic detection using case-control data

 

Detection mode

Screening

Symptomatic with a negative screen in the last 2 years

Symptomatic without a negative screen in the last 2 years

Number of cases

937

292

123

Tumour size, mm

12.00

19.00

20.00

(median and quartiles)

(9.00, 18.00)

(13.75, 25.00)

(13.50, 28.00)

Age at diagnosis

63

62

65

(median and quartiles)

(58, 68)

(56.75, 67)

(61,71)

Body mass index

25.65

24.78

24.45

(median and quartiles)

(23.23, 28.26)

(22.31, 27.65)

(22.71, 27.19)

Percentage mammographic density

13.51

15.71

14.77

(median and quartiles)

(6.33, 23.72)

(7.90, 29.44)

(9.04, 28.83)

Standardised total breast area

0.05

−0.32

−0.15

(median and quartiles)

(−0.67, 0.74)

(−1.04, 0.40)

(−0.73, 0.74)

Cases with no previous negative screening

17

0

13

Cases with 1 previous negative screening

200

22

57

Cases with 2 previous negative screenings

596

149

49

Cases with 3 previous negative screenings

124

121

4

Time since last negative screening, yearsa

2.01

1.19

2.67

(median and quartiles)

(1.79, 2.13)

(0.90, 1.57)

(2.24, 3.56)

  1. aFor cases with at least one previous negative screening